Literature DB >> 18461527

[Adder bites--clinical picture, diagnosis and management].

F Prenzel1, M Schulz, W Siekmeyer, W Rahn, W Kiess.   

Abstract

Adder bites are occasionally occurring envenoming emergencies. More than ten percent of the clinical courses are severe and even life-threatening. Children and elderly patients are over-represented in this group. Common symptoms comprise local edema, abdominal pain and vomiting, arterial hypotension and neurological disorders. First steps in the management are immobilization of the affected extremity, reassurance of the patient and application of analgetics. Anaphylaxis may occur and requires status adapted treatment. Persistent circulatory shock, protracted gastrointestinal or severe neurological symptoms, as well as rapidly progressing edema and airway obstruction are indications for antivenom treatment. Administration of antivenom results in prompt clinical improvement and in a significantly shorter hospital stay.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18461527     DOI: 10.1055/s-2008-1077221

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  4 in total

1.  Venomous snakebites in the Croatian North Dalmatia region.

Authors:  Robert Karlo; Boris Dželalija; Božidar Zupančić; Ivan Bačić; Tihomir Dunatov; Ante Kanjer; Rade Skarica; Srećko Sabalić; Nado Bukvic; Harry Nikolić; Goran Augustin
Journal:  Wien Klin Wochenschr       Date:  2011-11-29       Impact factor: 1.704

2.  [Snake bite in a 53-year-old female tourist].

Authors:  S Bertheau; A Aghdassi; M Otto; K Hegenscheid; S Runge; M M Lerch; P Simon
Journal:  Internist (Berl)       Date:  2015-02       Impact factor: 0.743

3.  [Adder bite. A rare dermatologic emergency].

Authors:  C Pföhler; T M Müller; W Tilgen
Journal:  Hautarzt       Date:  2010-07       Impact factor: 0.751

4.  [Surgical treatment of bites].

Authors:  D Saul; K Dresing
Journal:  Oper Orthop Traumatol       Date:  2018-09-12       Impact factor: 1.154

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.